A detailed history of Acadian Asset Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,900,002 shares of VNDA stock, worth $9.08 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,900,002
Previous 1,982,027 4.14%
Holding current value
$9.08 Million
Previous $11.2 Million 20.41%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$4.61 - $6.34 $378,135 - $520,038
-82,025 Reduced 4.14%
1,900,002 $8.91 Million
Q2 2024

Aug 06, 2024

SELL
$3.91 - $6.5 $1.52 Million - $2.52 Million
-388,308 Reduced 16.38%
1,982,027 $11.2 Million
Q1 2024

May 10, 2024

BUY
$3.47 - $4.61 $371,994 - $494,205
107,203 Added 4.74%
2,370,335 $9.74 Million
Q4 2023

Feb 13, 2024

BUY
$3.38 - $4.58 $1.73 Million - $2.35 Million
512,477 Added 29.27%
2,263,132 $9.55 Million
Q3 2023

Nov 13, 2023

BUY
$4.28 - $6.57 $2.62 Million - $4.02 Million
611,564 Added 53.69%
1,750,655 $7.56 Million
Q2 2023

Aug 07, 2023

BUY
$5.9 - $6.95 $591,469 - $696,730
100,249 Added 9.65%
1,139,091 $7.5 Million
Q1 2023

May 11, 2023

BUY
$6.18 - $7.99 $1.98 Million - $2.56 Million
320,482 Added 44.61%
1,038,842 $7.05 Million
Q4 2022

Feb 14, 2023

BUY
$6.87 - $10.96 $566,383 - $903,575
82,443 Added 12.96%
718,360 $5.3 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $5.74 Million - $7.15 Million
608,146 Added 2189.86%
635,917 $6.28 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $5.74 Million - $7.15 Million
608,146 Added 2189.86%
635,917 $6.28 Million
Q2 2022

Aug 09, 2022

SELL
$9.31 - $11.84 $3.24 Million - $4.12 Million
-348,296 Reduced 92.62%
27,771 $303,000
Q1 2022

May 12, 2022

SELL
$10.84 - $16.55 $582,248 - $888,950
-53,713 Reduced 12.5%
376,067 $4.25 Million
Q4 2021

Feb 10, 2022

SELL
$15.69 - $21.14 $1.38 Million - $1.86 Million
-87,819 Reduced 16.97%
429,780 $6.74 Million
Q3 2021

Nov 12, 2021

SELL
$15.35 - $21.27 $1.34 Million - $1.86 Million
-87,239 Reduced 14.42%
517,599 $8.87 Million
Q2 2021

Aug 11, 2021

SELL
$15.71 - $21.51 $5.46 Million - $7.48 Million
-347,639 Reduced 36.5%
604,838 $13 Million
Q1 2021

May 11, 2021

SELL
$13.42 - $20.28 $526,090 - $795,016
-39,202 Reduced 3.95%
952,477 $14.3 Million
Q4 2020

Feb 11, 2021

SELL
$9.77 - $13.81 $940,010 - $1.33 Million
-96,214 Reduced 8.84%
991,679 $13 Million
Q3 2020

Nov 09, 2020

BUY
$9.32 - $12.02 $164,283 - $211,876
17,627 Added 1.65%
1,087,893 $10.5 Million
Q2 2020

Aug 12, 2020

SELL
$9.66 - $12.02 $932,209 - $1.16 Million
-96,502 Reduced 8.27%
1,070,266 $12.2 Million
Q1 2020

May 11, 2020

BUY
$7.5 - $16.8 $1.36 Million - $3.05 Million
181,251 Added 18.39%
1,166,768 $12.1 Million
Q4 2019

Feb 06, 2020

BUY
$12.38 - $17.47 $2.11 Million - $2.98 Million
170,455 Added 20.91%
985,517 $16.2 Million
Q3 2019

Nov 07, 2019

BUY
$12.27 - $15.79 $3.19 Million - $4.1 Million
259,792 Added 46.79%
815,062 $10.8 Million
Q2 2019

Aug 08, 2019

SELL
$13.37 - $18.85 $949,497 - $1.34 Million
-71,017 Reduced 11.34%
555,270 $7.82 Million
Q1 2019

May 09, 2019

BUY
$17.59 - $31.05 $3.19 Million - $5.63 Million
181,237 Added 40.72%
626,287 $11.5 Million
Q4 2018

Feb 07, 2019

BUY
$18.97 - $31.47 $4.7 Million - $7.79 Million
247,639 Added 125.44%
445,050 $11.6 Million
Q3 2018

Oct 30, 2018

BUY
$18.25 - $23.0 $2.78 Million - $3.5 Million
152,137 Added 336.04%
197,411 $4.53 Million
Q2 2018

Jul 24, 2018

BUY
$13.95 - $19.15 $631,572 - $866,997
45,274 New
45,274 $862,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $270M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.